Complement Inhibition for the Treatment of Myasthenia Gravis

Complement Inhibition for the Treatment of Myasthenia Gravis

Renato Mantegazza, Fiammetta Vanoli, Rita Frangiamore, Paola Cavalcante Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, ItalyCorrespondence: Renato MantegazzaNeurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fond...

Full description

Bibliographic Details
Main Authors: Mantegazza R, Vanoli F, Frangiamore R, Cavalcante P
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:ImmunoTargets and Therapy
Subjects:
myasthenia gravis
complement system
biological drugs
c5
biomarkers
Online Access:https://www.dovepress.com/complement-inhibition-for-the-treatment-of-myasthenia-gravis-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/complement-inhibition-for-the-treatment-of-myasthenia-gravis-peer-reviewed-article-ITT

Similar Items